For foundations, family offices, and impact partners
The companies that will define 2040 are being written in labs right now. We partner with funders who understand that deep tech returns compound precisely because other capital is not patient enough to try.
Why it has to be patient capital
Today's VCs chase AI for a reason: fast returns, easily modelled. Deep tech is different by construction. A biotech company needs seven to ten years. A materials-science startup needs five to eight. Advanced manufacturing needs three to five just to prototype.
These timelines do not fit a ten-year fund with a three-year deployment window. So the capital does not show up, and the science sits in a drawer.
The Institute succeeds when fellows succeed. Our alignment is structural, not contractual. We do not take board seats. We do not force exits. We hold minority equity and provide long-term support.
We are looking for partners who understand that the best things take time, and who want to be part of a project that compounds for thirty years.
Unit economics
A deliberately simple structure, designed to be legible to a grant officer, a family office board, and a university treasurer in the same meeting.
Competitive compensation for an exceptional STEM graduate. Low enough to be fundable, high enough to be honest.
Split fifty-fifty. Competitive with consulting offers, so the Triangle stops winning by default.
Programme overhead included. EU and national grants reduce this further. A cohort of 10 runs well under €500K.
Exits fund the next cohort, not a GP carry. A modest spin-out rate creates a self-sustaining flywheel at scale.
Roadmap
Where we are, where we are going, and how your capital accelerates the specific step we are on.
Stand up the gGmbH, finalise the IP template, complete the map of European university innovation offices. Build the founding advisory board. Close first anchor funder.
Sign the founding partnership. Apply for EXIST and SPRIND support. Begin the fellow recruitment pipeline. Prove the model on paper before running it in a lab.
Scouting-stage only. Small, tight, observable. The goal is learning, not scale. Document everything so the second cohort runs cleanly.
Five to eight fellows across two or three universities. First spin-outs emerging. Cross-university research exchange active. Begin raising a standing endowment from patient partners.
Ways to participate
We design the partnership around what you care about, over the time horizon you can commit to.
Fund an entire cohort in your name or your foundation's. Early, visible, and formative for the Institute's direction.
You get direct access to the cohort, naming rights if desired, and a seat on the advisory board for the duration of the programme.
Fund a single fellow's stipend and programme costs. Lowest-friction way to back a specific researcher or topic area.
Ideal for smaller foundations, individual impact investors, or corporates who want to back deep tech without a commercial arrangement.
A long-horizon partnership to build a standing endowment. The vehicle funds cohorts indefinitely from retained equity and annuities.
For family offices and impact funds that want to be structural, not transactional. Terms co-designed, not templated.
The ask
We are looking for foundational partners for cohorts one through three. If the thesis resonates, we would like an hour of your time. No deck, no pitch, just a conversation.
In formation, 2026. Talking with TU Berlin, TransferAllianz, and SPRIND. First pilot cohort planned for Q4 2026.